Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size

Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size

This study investigated the management and clinical outcomes along with associated factors of posterior reversible encephalopathy syndrome (PRES) in childhood hematologic/oncologic diseases. We present data from children with hematologic/oncologic diseases who developed PRES after treatment of the p...

Full description

Bibliographic Details
Main Authors: Marady Hun, Min Xie, Zhou She, Amin S. Abdirahman, Cuifang Li, Feifeng Wu, Senlin Luo, Phanna Han, Rithea Phorn, Pan Wu, Haiyan Luo, Keke Chen, Jidong Tian, Wuqing Wan, Chuan Wen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pediatrics
Subjects:
posterior reversible encephalopathy syndrome
chemotherapy
hematopoietic stem cell transplantation
children
oncologic/hematologic diseases
neurotoxicity
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.678890/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2021.678890/full

Similar Items